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INTRODUCTION AND BACKGROUND
What brief cognitive test should a busy GP 
use when trying to assess someone who 
might have dementia? The menu of choices 
is long; one review found 11 options.1
The Cochrane Dementia and Cognitive 
Improvement Group (CDCIG) is conducting 
a series of reviews to evaluate the evidence 
of a range of tests for diagnosing dementia. 
To date, reviews have been published 
addressing the accuracy of two tests in 
primary care: the Informant Questionnaire for 
Cognitive Disorders in the Elderly (IQCODE) 
and the Mini Mental State Examination 
[MMSE]. Reviewers found only one study 
that investigated the use of the IQCODE in 
primary care,2 and six that investigated the 
use of the MMSE.3
A review of the Montreal Cognitive 
Assessment [MoCA] found no studies that 
evaluated the accuracy of the test in primary 
care.4 Reviews are underway for the Mini-
Cog and AD-8 tests (see http://dta.cochrane.
org/reviews-and-protocols-crg). 
REVIEW OF EVIDENCE FOR THE 
DIAGNOSTIC ACCURACY OF THE IQCODE 
IN PRIMARY CARE
The IQCODE is a structured informant 
questionnaire; 26-item and 16-item 
versions exist and scores range from 1 (no 
impairment) to 5 (more impairment).4
In the one study that investigated the 
use of the IQCODE at a threshold of 3.2 in 
primary care the sensitivity was 100% and 
specificity 76%, whereas at a threshold of 3.7 
the sensitivity was 75% and specificity 98%.2 
REVIEW OF EVIDENCE FOR THE 
DIAGNOSTIC ACCURACY OF THE MMSE IN 
PRIMARY CARE
The MMSE is one of the oldest and therefore 
most well-known cognitive tests for 
dementia, though it may now be less likely 
to be used by clinicians due to copyright 
fees. The Cochrane review identified 24 310 
articles, of which 317 full-text articles were 
reviewed and 70 records (referring to 48 
studies) were included. Of the 48 included 
studies, six were in primary care and 42 
were in unselected members of the general 
community aged >65 years.
PRIMARY CARE STUDIES
Of the six primary care studies, two were 
conducted in patients who were presenting 
with symptoms of dementia and four were in 
patients attending primary care regardless of 
concerns about dementia. The prevalence of 
dementia would be expected to be higher in 
people with symptoms and this would affect 
the accuracy of the test. 
No study was judged as being at high risk 
of bias in more than two of four areas.
Figure 1 presents the Forest plot for the 
sensitivity and specificity of studies in primary 
care. There were too few studies to perform 
meta-analysis of the accuracy of any one 
cut-point.
Symptomatic patients
In symptomatic patients (that is, patients 
presenting with memory problems) in 
primary care the accuracy of the MMSE for 
the diagnosis of dementia was available for 9 
cut-points (17 to 25 inclusive) in two different 
studies. Only one study (Carnero-Pardo 2013) 
reported the traditional cut point of 24, with 
an accuracy of sensitivity 1.00 (95% CI = 0.95 
to 1.00) and specificity 0.46 (95% CI = 0.40 to 
0.52). 
Asymptomatic patients
In asymptomatic patients the accuracy of 
the MMSE for the diagnosis of dementia was 
available for 9 cut-points (18 to 26 inclusive) 
in four different studies. At the traditional cut-
point of 24, Lourenco 2006 (Brazil) reported 
a sensitivity of 0.81 (95% CI = 0.70 to 0.89) 
and specificity of 0.65 (95% CI = 0.59 to 0.72), 
whereas Pond 1994 (Australia) reported a 
sensitivity of 0.37 (95% CI = 0.24 to 0.51) and 
specificity of 0.95 (95% CI = 0.92 to 0.97). The 
prevalence of dementia in Lourenco 2006 
was higher than in other studies and this may 
explain the difference in findings.
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WHAT ABOUT SCREENING?
Screening for dementia in the general 
population is not currently recommended by 
the UK screening committee.5 
WHAT ISSUES WITH COGNITIVE TESTS 
SHOULD GPs BE AWARE OF?
Specific patients may present problems; 
in particular, the presence of sensory 
impairment, coexisting morbidity, and learning 
and/or language difficulties may make the 
assessment particularly challenging.
GPs should be aware that it is possible 
that someone might have dementia even 
with a very high ‘score’ that is well above 
the normal cut-point to identify cognitive 
impairment. Education has an important 
confounding effect on the scores obtained on 
brief cognitive tests and diagnostic criteria for 
dementia are clear that the relevant finding is 
a decline in cognition from a previous higher 
level that interferes with daily life, and is not 
better explained by another mental disorder.
The accuracy of brief cognitive tests for 
identifying less common cognitive disorders, 
such as frontotemporal dementia and Lewy 
body dementia, is not established in primary 
care.
WILL FUTURE RESEARCH HELP?
A prospective test accuracy study based in 
primary care is currently under way that will 
evaluate the accuracy of a range of tests for 
diagnosing dementia in a symptomatic group 
of people recruited from primary care.6
SO WHAT SHOULD THE BUSY GP DO?
A guide for clinicians from the Alzheimer’s 
Society7 recommends the use of the 
Abbreviated Mental Test Score (<5 minutes), 
GPCOG (5 minutes), or Mini-Cog (2–4 minutes) 
as part of the assessment for identifying, 
dementia in primary care. The authors 
preference in practice is to use the GPCOG 
because it assesses recall and visuospatial 
skills, together with an informant interview, 
and is brief. The GPCOG also asks particularly 
about difficulties with managing medications, 
finances, and gadgets as there is evidence 
that people with dementia may struggle with 
these tasks.8,9 Younger patients (<70 years) 
with symptoms that are acknowledged by an 
informant present a particular challenge, and 
in practice the authors would exclude affective 
disorder and then have a low threshold for 
seeking advice. For older people (>90 years) 
with multimorbidity (for example, in a nursing 
home) it might be more appropriate to focus 
on managing distress and advance care 
planning. No cognitive test appears to have 
sufficient accuracy, by itself, to rule in or 
rule out dementia. Given the limitations of 
existing tests and the available evidence, GPs 
should also value their own judgement based 
on clinical history and discussion with an 
informant.
AN IMPORTANT REMINDER
It is important that clinicians assess the 
risks to the patient and others, for example, 
with medications (including anticoagulants), 
cooking, fires, machinery, or driving.
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Figure 1. Forest plot of primary care studies.3 
aCarnero-Pardo 2013 and Cruz-Orduna 2012 were 
in symptomatic patients. CI = confidence interval. 
FN = false negative. FP = false positive. TN = true 
negative. TP = true positive.
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